0001415889-22-001742.txt : 20220223
0001415889-22-001742.hdr.sgml : 20220223
20220223202345
ACCESSION NUMBER: 0001415889-22-001742
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220218
FILED AS OF DATE: 20220223
DATE AS OF CHANGE: 20220223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moreland Mary K
CENTRAL INDEX KEY: 0001783147
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 22665941
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
form4-02232022_050234.xml
X0306
4
2022-02-18
0000001800
ABBOTT LABORATORIES
ABT
0001783147
Moreland Mary K
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064
false
true
false
false
EXECUTIVE VICE PRESIDENT
Common shares without par value
2022-02-18
4
A
0
15813
0
A
88158
D
Common shares without par value
2022-02-22
4
F
0
793
116.79
D
87365
D
Common shares without par value
2021-02-22
4
S
0
400
119.3067
D
86965
D
Common shares without par value
10986
I
Profit Sharing Trust
Option (right to buy)
117.58
2022-02-18
4
A
0
73696
0
A
2023-02-18
2032-02-17
Common Shares
73696
73696
D
These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.3003 to $119.3100, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Balance in the Abbott Laboratories Stock Retirement Trust as of February 18, 2022.
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 24,565 on February 18, 2023, 24,565 on February 18, 2024, and 24,566 on February 18, 2025.
The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).
/s/ Mary K. Moreland by Jessica H. Paik, Attorney-in-Fact
2022-02-23